Nothing Special   »   [go: up one dir, main page]

FI963831A - Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten - Google Patents

Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten Download PDF

Info

Publication number
FI963831A
FI963831A FI963831A FI963831A FI963831A FI 963831 A FI963831 A FI 963831A FI 963831 A FI963831 A FI 963831A FI 963831 A FI963831 A FI 963831A FI 963831 A FI963831 A FI 963831A
Authority
FI
Finland
Prior art keywords
hormone
preparation
pct
estrogen
daily
Prior art date
Application number
FI963831A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963831A0 (fi
Inventor
Ursula Lachnit
Bernd Duesterberg
Juergen Spona
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6514578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963831(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI963831A0 publication Critical patent/FI963831A0/fi
Publication of FI963831A publication Critical patent/FI963831A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FI963831A 1994-03-30 1996-09-25 Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten FI963831A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4411585A DE4411585A1 (de) 1994-03-30 1994-03-30 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PCT/EP1995/001190 WO1995026730A1 (de) 1994-03-30 1995-03-30 Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption

Publications (2)

Publication Number Publication Date
FI963831A0 FI963831A0 (fi) 1996-09-25
FI963831A true FI963831A (fi) 1996-11-29

Family

ID=6514578

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963831A FI963831A (fi) 1994-03-30 1996-09-25 Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten

Country Status (25)

Country Link
US (1) US5756490A (bg)
EP (1) EP0750501B1 (bg)
JP (1) JPH09511243A (bg)
KR (1) KR100352571B1 (bg)
CN (1) CN1108800C (bg)
AT (1) ATE222494T1 (bg)
AU (1) AU2073595A (bg)
BG (1) BG63192B1 (bg)
BR (1) BR9507251A (bg)
CA (1) CA2186739A1 (bg)
CZ (1) CZ291698B6 (bg)
DE (2) DE4411585A1 (bg)
DK (1) DK0750501T3 (bg)
ES (1) ES2181770T3 (bg)
FI (1) FI963831A (bg)
HU (1) HUT75521A (bg)
NO (1) NO964089L (bg)
NZ (1) NZ282824A (bg)
PL (1) PL316569A1 (bg)
PT (1) PT750501E (bg)
RO (1) RO118375B1 (bg)
RU (1) RU2165258C2 (bg)
SK (1) SK124396A3 (bg)
UA (1) UA41401C2 (bg)
WO (1) WO1995026730A1 (bg)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
ATE264106T1 (de) * 1994-11-22 2004-04-15 Balance Pharmaceuticals Inc Verfahren zur empfängnisverhütung
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
AU726283B2 (en) * 1995-06-28 2000-11-02 Schering Aktiengesellschaft Pharmaceutical combined preparations, kit and method for hormonal contraception
AU2815897A (en) * 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
ES2223081T3 (es) * 1996-07-26 2005-02-16 Wyeth Metodo anticonceptivo oral monofasico y kit que comprende una combinacion de progestina y estrogeno.
AU3888697A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Progestin/estrogen oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
AU713016B2 (en) * 1996-07-26 1999-11-18 Wyeth Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
ATE420648T1 (de) * 1999-08-31 2009-01-15 Bayer Schering Pharma Ag Pharmazeutische kombination von ethinylestradiol und drospirenon als empfängnisverhütendes mittel
EE05317B1 (et) * 1999-08-31 2010-08-16 Bayer Schering Pharma Aktiengesellschaft Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
SI1453521T1 (sl) * 2001-12-05 2013-11-29 Teva Women's Health, Inc. Oralni kontraceptiki za preprečevanje nosečnosti in zmanjševanje predmenstrualne simptomatike
US7855190B2 (en) * 2003-07-16 2010-12-21 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20050090475A1 (en) * 2003-10-01 2005-04-28 Laguardia Katherine D. Extended triphasic contraceptive regimens
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (bg) * 1966-11-02 1968-05-03
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (bg) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
MX9604440A (es) 1997-07-31
NO964089L (no) 1996-11-07
FI963831A0 (fi) 1996-09-25
KR100352571B1 (ko) 2003-01-06
NZ282824A (en) 1998-07-28
BG100940A (bg) 1998-03-31
DE59510333D1 (de) 2002-09-26
PT750501E (pt) 2003-01-31
DK0750501T3 (da) 2002-12-23
ES2181770T3 (es) 2003-03-01
JPH09511243A (ja) 1997-11-11
DE4411585A1 (de) 1995-10-05
CN1108800C (zh) 2003-05-21
BG63192B1 (bg) 2001-06-29
CA2186739A1 (en) 1995-10-12
UA41401C2 (uk) 2001-09-17
RU2165258C2 (ru) 2001-04-20
RO118375B1 (ro) 2003-05-30
NO964089D0 (no) 1996-09-27
AU2073595A (en) 1995-10-23
CZ291698B6 (cs) 2003-05-14
WO1995026730A1 (de) 1995-10-12
SK124396A3 (en) 1997-05-07
EP0750501B1 (de) 2002-08-21
CZ287996A3 (en) 1997-02-12
EP0750501A1 (de) 1997-01-02
CN1159161A (zh) 1997-09-10
HUT75521A (en) 1997-05-28
BR9507251A (pt) 1997-09-02
HU9602657D0 (en) 1996-11-28
ATE222494T1 (de) 2002-09-15
US5756490A (en) 1998-05-26
PL316569A1 (en) 1997-01-20

Similar Documents

Publication Publication Date Title
FI963831A (fi) Farmaseuttinen yhdistelmävalmiste hormonaalista ehkäisyä varten
PT835114E (pt) Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal
ATE136781T1 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
NO974630L (no) Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon
Van Santen et al. Interception II: postcoital low-dose estrogens and norgestrel combination in 633 women

Legal Events

Date Code Title Description
FD Application lapsed